Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GATIFLOXACIN vs GEMFIBROZIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GATIFLOXACIN vs GEMFIBROZIL: Safety Overview

Metric GATIFLOXACIN GEMFIBROZIL
Total FAERS Reports 341 1,089
Deaths Reported 7 101
Death Rate 2.1% 9.3%
Hospitalizations 30 286
Average Patient Age 62.5 yrs 56.7 yrs
% Female Patients 76.2% 49.9%
FDA Approval Date Aug 19, 2011 Approved Prior to Jan 1, 1982
Manufacturer Allergan, Inc. Northwind Health Company, LLC
Route OPHTHALMIC ORAL
Marketing Status Discontinued Discontinued